<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37080570</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1399-3003</ISSN><JournalIssue CitedMedium="Internet"><Volume>61</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>The European respiratory journal</Title><ISOAbbreviation>Eur Respir J</ISOAbbreviation></Journal><ArticleTitle>Eight lessons from 2 years of use of the Post-COVID-19 Functional Status scale.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2300416</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1183/13993003.00416-2023</ELocationID><Abstract><AbstractText><b>Based on the literature and users&#x2019; experiences, lessons could be learned after 2 years&#x2019; use of the Post-COVID-19 Functional Status (PCFS) scale, that could contribute to its optimal use. All in all, the PCFS scale provided added value during the pandemic.</b> https://bit.ly/3KkI5Ak</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Jong</LastName><ForeName>Cindy M M</ForeName><Initials>CMM</Initials><Identifier Source="ORCID">0000-0002-2310-5820</Identifier><AffiliationInfo><Affiliation>Department of Medicine - Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le</LastName><ForeName>Y N Jenny</ForeName><Initials>YNJ</Initials><Identifier Source="ORCID">0000-0003-0729-4016</Identifier><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boon</LastName><ForeName>Gudula J A M</ForeName><Initials>GJAM</Initials><Identifier Source="ORCID">0000-0003-4532-436X</Identifier><AffiliationInfo><Affiliation>Department of Medicine - Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barco</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-2618-347X</Identifier><AffiliationInfo><Affiliation>Department of Angiology, University Hospital Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Thrombosis and Hemostasis, University Hospital Mainz, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klok</LastName><ForeName>Frederikus A</ForeName><Initials>FA</Initials><Identifier Source="ORCID">0000-0001-9961-0754</Identifier><AffiliationInfo><Affiliation>Department of Medicine - Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siegerink</LastName><ForeName>Bob</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-8454-9142</Identifier><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands b.siegerink@lumc.n.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Respir J</MedlineTA><NlmUniqueID>8803460</NlmUniqueID><ISSNLinking>0903-1936</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000085542" MajorTopicYN="N">Functional Status</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="eng"><AbstractText>The number of confirmed cases of coronavirus disease 2019 (COVID-19) worldwide exceeded 750&#x2005;million as of February 2023 [1], leaving an estimated 65&#x2005;million individuals experiencing post-acute sequelae of COVID-19 or &#x201c;long COVID&#x201d;, or a modelled estimate of 6.2% of individuals experiencing long COVID symptoms 3 months after symptomatic SARS-CoV-2 infection [2, 3]. Early in the pandemic, we proposed the Post-COVID-19 Functional Status (PCFS) scale in the <i>European Respiratory Journal</i> [4], which resulted from a slight adaptation of the Post-Venous thromboembolism Functional Status (PVFS) scale developed in 2019 [5, 6]. The PCFS scale is designed to monitor functional recovery and identify patients with incomplete or poor recovery after COVID-19 in research and clinical practice.</AbstractText></OtherAbstract><CoiStatement>Conflict of interest: S. Barco reports institutional research grants from Concept Medical, Bard, Bentley, Boston Scientific, INARI, Sanofi and Bayer, and personal fees from Concept Medical, Bayer, Boston Scientific and INARI, outside the submitted work. F.A. Klok reports grants from Bayer, BMS, BSCI, MSD, Leo Pharma, Actelion, VarmX, The Netherlands Organisation for Health Research and Development, The Dutch Thrombosis Association, The Dutch Heart Foundation and the Horizon Europe Program, outside the submitted work. All other authors have nothing to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>21</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>20</Day><Hour>20</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37080570</ArticleId><ArticleId IdType="pmc">PMC10151454</ArticleId><ArticleId IdType="doi">10.1183/13993003.00416-2023</ArticleId><ArticleId IdType="pii">13993003.00416-2023</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization . WHO Coronavirus (COVID-19) Dashboard. Date last accessed: 7 February 2023.
https://covid19.who.int/</Citation></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, et al. . Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 2023; 21: 133&#x2013;146. doi:10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson S Wulf, Abbafati C, Aerts JG, et al. . Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA 2022; 328: 1604&#x2013;1615. doi:10.1001/jama.2022.18931</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Boon GJAM, Barco S, et al. . The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19. Eur Respir J 2020; 56: 2001494. doi:10.1183/13993003.01494-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01494-2020</ArticleId><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Barco S, Siegerink B. Measuring functional limitations after venous thromboembolism: a call to action. Thromb Res 2019; 178: 59&#x2013;62. doi:10.1016/j.thromres.2019.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2019.04.003</ArticleId><ArticleId IdType="pubmed">30980999</ArticleId></ArticleIdList></Reference><Reference><Citation>Boon GJAM, Barco S, Bertoletti L, et al. . Measuring functional limitations after venous thromboembolism: optimization of the Post-VTE Functional Status (PVFS) Scale. Thromb Res 2020; 190: 45&#x2013;51. doi:10.1016/j.thromres.2020.03.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.03.020</ArticleId><ArticleId IdType="pubmed">32298840</ArticleId></ArticleIdList></Reference><Reference><Citation>Sociedades Cient&#xed;ficas y Colegios Profesionales del &#xe1;rea de rehabilitaci&#xf3;n . Consenso Interdisciplinario de Rehabilitaci&#xf3;n para Personas Adultas Post COVID-19. Recomendaciones para la pr&#xe1;ctica cl&#xed;nica. Sociedades Cient&#xed;ficas y Colegios Profesionales del &#xe1;rea de rehabilitaci&#xf3;n, 2020.</Citation></Reference><Reference><Citation>Rabady S, Altenberger J, Brose M, et al. . Leitlinie S1: Long COVID: Differenzialdiagnostik und Behandlungsstrategien. [Guideline S1: Long COVID: Diagnostics and treatment strategies]. Wien Klin Wochenschr 2021; 133: Suppl. 7, 237&#x2013;278. doi:10.1007/s00508-021-01974-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00508-021-01974-0</ArticleId><ArticleId IdType="pmc">PMC8633909</ArticleId><ArticleId IdType="pubmed">34851455</ArticleId></ArticleIdList></Reference><Reference><Citation>Koczulla AR, Ankermann T, Behrends U, et al. . S1-Leitlinie Post-COVID/Long-COVID. [S1 Guideline Post-COVID/Long-COVID]. Pneumologie 2021: 75: 869&#x2013;900. doi:10.1055/a-1551-9734</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1551-9734</ArticleId><ArticleId IdType="pubmed">34474488</ArticleId></ArticleIdList></Reference><Reference><Citation>Servei Catal&#xe0; de la Salut . Guia cl&#xed;nica per a l'atenci&#xf3; de les persones amb s&#xed;mptomes persistents de COVID-19. Generalitat de Catalunya, 2021.</Citation></Reference><Reference><Citation>Swaminathan N, Jiandani M, Surendran PJ, et al. . Beyond COVID-19: evidence-based consensus statement on the role of physiotherapy in pulmonary rehabilitation in the Indian context. J Assoc Physicians India 2020; 68: 82&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">33247653</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Clinical Management of COVID-19: Living Guideline, 15 September 2022. Geneva, World Health Organization, 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">35917394</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegerink B, Boon GJAM, Barco S, et al. The Post-COVID-19 Functional Status (PCFS) Scale: a tool to measure functional status over time after COVID-19. doi: 10.17605/OSF.IO/QGPDV. Date last updated: 14 April 2023. Date last accessed: 03 January 2023.</Citation><ArticleIdList><ArticleId IdType="doi">10.17605/OSF.IO/QGPDV</ArticleId><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegerink B, Klok FA, Le YNJ. Use of the PCFS two years after its introduction &#x2013; a literature review and survey amongst users. Date last updated: 05 January 2023. 10.17605/OSF.IO/H5EQU</Citation><ArticleIdList><ArticleId IdType="doi">10.17605/OSF.IO/H5EQU</ArticleId></ArticleIdList></Reference><Reference><Citation>Du HW, Fang SF, Wu SR, et al. . Six-month follow-up of functional status in discharged patients with coronavirus disease 2019. BMC Infect Dis 2021: 21: 1271. doi:10.1186/s12879-021-06970-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06970-3</ArticleId><ArticleId IdType="pmc">PMC8686090</ArticleId><ArticleId IdType="pubmed">34930161</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>